Inhibition of Medulloblastoma growth by a sonic hedgehog (SHH) inhibitor
收藏官方服务：
资源简介：
Inhibition of Medulloblastoma growth by a sonic hedgehog (SHH) inhibitor
应用场景：
创建时间：
2016-03-14
相关数据集
HDACi and PLK1i synergize in MYC-amplified MB. HDACi and PLK1i synergize in MYC-amplified MB
We and others have demonstrated that MYC-amplified medulloblastoma (MB) cells are susceptible towards treatment with class I histone deacetylase inhibitors (HDACi). However, single drug treatment with
NIAID Data Ecosystem120
DataSheet_1_Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor.docx
Neuroblastoma is the most common extracranial neuroendocrine tumor in childhood. Although many studies have tried to find effective treatments, there are still numerous limitations in current clinical
NIAID Data Ecosystem40
DataSheet_1_PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449.pdf
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood and has a poor prognosis in high-risk cases, requiring novel therapies. Pathways that depend on phospho-signaling maintain t
NIAID Data Ecosystem30
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition. Homo sapiens
Bromodomain inhibition comprises a promising therapeutic strategy in cancer, particularly for hematologic malignancies. To date, however, genomic biomarkers to direct clinical translation have been la
NIAID Data Ecosystem90
dBET57 exerts anti-cancer effects in neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid tumor of childhood, which is derived from primordial neural crest cells. dBET57, a new cereblon (CRBN) based inhibitor developed by PROTAC tech
NIAID Data Ecosystem30
